Heather A. Wakelee

Cancer Prevention Institute of California

Also affiliated with Palo Alto Institute, Stanford Medicine, Stanford Cancer Institute, Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.109Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423

Top 72%

0.109DataRank

Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Papers

Driven by 51 papers — median percentile 28. Top paper: “Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer”.

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2302983

N/A

7.3DataRank · unranked

1056 citations

Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi, Se‐Hoon Lee, Shugeng Gao +14 more

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet(2024)10.1016/s0140-6736(24)01756-2

N/A

3.7DataRank · unranked

262 citations

Marina Chiara Garassino, Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi +91 more

Tobacco Smoking and Risk of Second Primary Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.02.024

N/A

3.6DataRank · unranked

131 citations

Sophia J. Luo, Rebecca M. Gardner, Nilotpal Sanyal, Eunji Choi, Thomas Hickey +20 more

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.017

N/A

0.975DataRank · unranked

662 citations

Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési +23 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0282

N/A

0.775DataRank · unranked

174 citations

Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Y. Nabet, Diego Almanza +26 more

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.01.1628

N/A

0.731DataRank · unranked

130 citations

Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda +11 more

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3418

N/A

0.723DataRank · unranked

123 citations

Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark Dunphy +30 more

Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1385

N/A

0.723DataRank · unranked

123 citations

Chuan Li, Hongchen Cai, Jessica A. Hellyer, Wen-Yang Lin, Deborah Ayeni +15 more

Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors

JACC CardioOncology(2021)10.1016/j.jaccao.2021.01.004

N/A

0.721DataRank · unranked

121 citations

Joel W. Neal, Sunil Reddy, Heather A. Wakelee, Sumit Shah, Sandy Srinivas +7 more

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00082-1

N/A

0.708DataRank · unranked

111 citations

Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi +44 more

Radiological tumour classification across imaging modality and histology

Nature Machine Intelligence(2021)10.1038/s42256-021-00377-0

N/A

0.685DataRank · unranked

95 citations

Chao Li, Michael F. Gensheimer, Sukhmani K. Padda, Fumi Kato, Hiroki Shirato +11 more

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Cancer Cell(2020)10.1016/j.ccell.2020.05.008

N/A

0.614DataRank · unranked

59 citations

Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini +12 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0.571DataRank · unranked

44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2020.12.017

N/A

0.505DataRank · unranked

28 citations

Opeyemi A. Jegede, Suzanne E. Dahlberg, Heather A. Wakelee, Steven M. Keller, William Tester +7 more

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.11.020

N/A

0.494DataRank · unranked

26 citations

Robyn Du, Nathaniel J. Myall, Whitney E. Lewis, Natalie Uy, Lingzhi Hong +22 more

The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab224

N/A

0.489DataRank · unranked

25 citations

Sophia J. Luo, Jacqueline V. Aredo, Leah M. Backhus, Lynne R. Wilkens, Chloe C. Su +6 more

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.08.016

N/A

0.449DataRank · unranked

19 citations

Murry W. Wynes, Casey Connolly, Kazuto Ashizawa, Sukhinder Atkar-Khattra, Chandra P. Belani +25 more

Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab138

N/A

0.425DataRank · unranked

16 citations

Nilotpal Sanyal, Victoria Y. Ding, Rebecca M. Gardner, Jacqueline V. Aredo, Justin Lee +15 more

A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study

The Oncologist(2021)10.1002/onco.13725

N/A

0.413DataRank · unranked

5 citations

Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Sharyn I. Katz, Thomas J. FitzGerald +10 more

A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100174

N/A

0.406DataRank · unranked

14 citations

Nadine S. Jahchan, Millie Das, Michael Zach Koontz, Pamela L. Kunz, Heather A. Wakelee +4 more

Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy

JACC CardioOncology(2025)10.1016/j.jaccao.2025.06.009

N/A

0.385DataRank · unranked

12 citations

Maja Ivanovic, Antonia Chan, Sidra Xu, Miguel Franquiz, Carissa Lee +19 more

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9014

N/A

0.373DataRank · unranked

11 citations

Mark Krailo, Sukhmani K. Padda, Susan Groshen, Heather A. Wakelee, Karen L. Reckamp +14 more

Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes

JCO Precision Oncology(2022)10.1200/po.22.00220

N/A

0.360DataRank · unranked

10 citations

Victoria Y. Ding, Sophia Luo, Eunji Choi, Jessica Hellyer, Nathaniel Myall +10 more

Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model

Cancer(2023)10.1002/cncr.35069

N/A

0.345DataRank · unranked

9 citations

Sophia J. Luo, Victoria Y. Ding, Julie Wu, Ashok V. Kumar, Jason A. Wampfler +15 more

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

Annals of Oncology(2025)10.1016/j.annonc.2025.09.140

N/A

0.345DataRank · unranked

9 citations

Y. Xia, Ke Pan, Fangdi Sun, Aaron C. Tan, Xinran Dong +31 more

Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.06.006

N/A

0.292DataRank · unranked

6 citations

Isabelle Blanchard, Sukhmani K. Padda, Heather A. Wakelee, Joel W. Neal, Arpeet T. Shah

Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillance

npj Digital Medicine(2025)10.1038/s41746-025-02009-y

N/A

0.269DataRank · unranked

5 citations

Anna Graber‐Naidich, Mengrui Zhang, Rakshit Kaushik, Grant M. Nieda, Tony Chen +22 more

Genetic determinants of EGFR -Driven Lung Cancer Growth and Therapeutic Response In Vivo

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.13.036921

N/A

0.243DataRank · unranked

3 citations

Chuan Li, Hongchen Cai, Jessica A. Hellyer, Wen-Yang Lin, Deborah Ayeni +15 more

Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups

Annals of Internal Medicine(2025)10.7326/annals-25-00464

N/A

0.165DataRank · unranked

2 citations

Victoria Y. Ding, Kevin ten Haaf, Julie Wu, Neal D. Freedman, Leah M. Backhus +13 more

Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae072

N/A

0.165DataRank · unranked

2 citations

Yue Hua, Chloe C. Su, Julie Wu, Joel W. Neal, Ann N. Leung +8 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423

Top 72%

0.109DataRank

Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9012

N/A

0.104DataRank · unranked

1 citations

Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Y. Nabet, Diego Almanza +15 more

A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9046

N/A

0.104DataRank · unranked

1 citations

Mohammad Shahrokh Esfahani, Barzin Y. Nabet, Yufei Liu, Jacob J. Chabon, Jianzhong He +15 more

Molecularly Targeted Cancer Medications and Kidney Health

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.41221

N/A

0DataRank · unranked

2 citations

Jin Long, Yutong Zhong, Hannah Morgan‐Cooper, Heather A. Wakelee, Ali Raza Khaki +5 more

Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer

medRxiv(2025)10.1101/2025.03.10.25323586

N/A

0DataRank · unranked

0 citations

Christina S. Baik, Joel W. Neal, Fangdi Sun, Rafael Santana-Dávila, Sylvia Lee +13 more

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100914

N/A

0DataRank · unranked

0 citations

Caressa Hui, Joel W. Neal, Seema Nagpal, Mohana Roy, Millie Das +6 more

CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.888

N/A

0DataRank · unranked

0 citations

Heather A. Wakelee, Joel W. Neal, Kavitha Ramchandran, Millie Das, Seema Nagpal +5 more

Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac033

N/A

0DataRank · unranked

48 citations

Eunji Choi, Victoria Y. Ding, Martin C. Tammemägi, Kevin ten Haaf, Sophia J. Luo +9 more

Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2021.100274

N/A

0DataRank · unranked

8 citations

Yating Wang, Zhuoxin Sun, Heather A. Wakelee, Suresh S. Ramalingam, Joan Schiller +1 more

Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab076

N/A

0DataRank · unranked

9 citations

Eunji Choi, Jacqueline V. Aredo, Lynne R. Wilkens, Martin C. Tammemägi, Loı̈c Le Marchand +4 more

Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.010

N/A

0DataRank · unranked

42 citations

Zofia Piotrowska, Kevin Stirling, Stephen V. Liu, Mandeep K. Banwait, Kristen Cunanan +5 more

Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women’s Health Initiative

UNC Libraries(2020)10.17615/v7x4-gd59

N/A

0DataRank · unranked

0 citations

Lucile L. Adams‐Campbell, Ange Wang, Scarlett Lin Gomez, Rowan T. Chlebowski, Heather A. Wakelee +8 more

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.35813

N/A

0DataRank · unranked

12 citations

Julie Wu, Eunji Choi, Nathaniel J. Myall, Joel W. Neal, Allison W. Kurian +8 more

Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry

Scientific Reports(2023)10.1038/s41598-023-46458-5

N/A

0DataRank · unranked

11 citations

Danny Pancirer, Jordan S. Preiss, Jalen Benson, Winston Trope, Joseph B. Shrager +6 more

Osimertinib-Associated Cardiomyopathy In Patients With Non-Small Cell Lung Cancer

JACC CardioOncology(2023)10.1016/j.jaccao.2023.07.006

N/A

0DataRank · unranked

8 citations

Sarah Waliany, Audrey Xu, Anna P. Hnatiuk, Sean M. Wu, Paul Cheng +5 more

Software Application Profile:dynamicLM—a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risks

International Journal of Epidemiology(2023)10.1093/ije/dyad122

N/A

0DataRank · unranked

6 citations

Eunji Choi, Julie Wu, Justin Lee, Victoria Y. Ding, Robert J. Huang +6 more

A Moving Target: Integration of Smoking Cessation Into Screening for Second Primary Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.05.008

N/A

0DataRank · unranked

0 citations

Heather A. Wakelee, Summer S. Han, Jacqueline V. Aredo

Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.08.017

N/A

0DataRank · unranked

5 citations

Eunji Choi, Julie Wu, Timothy Ellis-Caleo, Joel W. Neal, Heather A. Wakelee +3 more

A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated Myocarditis

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.30.576279

N/A

0DataRank · unranked

5 citations

Daniel Lee, Yin Sun, Harrison Chou, Bruce Xu, Zachary Lin +13 more

THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY

medRxiv(2024)10.1101/2024.01.22.24301442

N/A

0DataRank · unranked

4 citations

Antonia Chan, Evaline Cheng, Sidra Xu, Carissa Lee, Jonathan You +17 more

Heather A. Wakelee

Indexed papers

Top data-sharing exemplar

Papers